As an Internist practicing for 35 years I have seen most common and many very uncommon illnesses. Restless legs syndrome (RLS) is a chronic sensorimotor disorder characterized by an urge to move the legs. This urge is often accompanied by pain or other uncomfortable and unpleasant sensations, it either occurs or worsens during rest, particularly in the evening and/or at night, and temporarily im …
RESTLESS LEGS SYNDROME AND CANNABIDIOL (CBD)
As an Internist practicing for 35 years I have seen most common and many very uncommon illnesses.
Restless Legs Syndrome (RLS) is real and there are millions of Americans who suffer from some form of RLS.
RLS is characterized by leg discomfort or pain that is only partially relieved by moving ones legs; hence the restless legs.
RLS is an illness often difficult to treat with traditional allopathic meds, so I was interested in seeing what happening when I began seeing patients with RLS in my cannabis medicine practice.
Well, now I have seen five patients with RLS. Three of the patients have had nearly complete cessation of their symptoms and the the two had marked improvement.
The dose seems to be fine taken just before sleep. In the unlikely situation that the patient awakens in the AM and has any troublesome psycho activity, they can simply take 4-6 mg CBD sublingually and will be much clearer very soon.
It is critical to remember, as I have written in many, many blogs, hemp based CBD has minimal effects.Hemp works very poorly because it is missing most of the other cannabinoids, terpenes and flavonoids. It is never just a “one molecule deal”. It is the entourage effect of all of natures medicine working together, not just CBD. Always look for whole plant CBD, not hemp
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient’s specific issues defined. Plant medicine requires “tuning” of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed
You Might Also Enjoy.
Dr Frankel talks about Trigeminal Neuralgia and the positive effect he has seen cannabis have on patients dealing with it. Some feedback received by three recent patients is also included.
Dr Frankel talks about his experience with prostate cancer therapies that have reduced his testosterone and the effect it has had on his life.
With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.
There are “acid” and “neutral” forms of every cannabinoid molecule. Early man knew the difference and would either just eat the cannabis raw, or heat it to convert to the neutral or “active” forms of the cannabinoids.
Cookie Bekkar is a cancer survivor and patient of Dr Frankel’s. She has created a website to share her story, what worked well for her and as a resource help inspire/educate other patients.
Early studies in both Israel and Canada show findings consistent with CBD’s effect on COVID-19’s ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.
Cannabis for Restless Legs Syndrome
Restless legs syndrome (RLS) is a chronic sensorimotor disorder characterized by an urge to move the legs. This urge is often accompanied by pain or other uncomfortable and unpleasant sensations, it either occurs or worsens during rest, particularly in the evening and/or at night, and temporarily improves with activity. Affecting nearly 3% of the North American and European populations in its moderate-to-severe form, RLS has a considerable negative impact on the quality of life, and sleep and is associated with significant morbidity. Although new developments have deepened our understanding of the disorder, yet, the corresponding pathophysiologic features that underlie the sensorimotor presentation are still not fully understood. Usually, symptoms respond well to dopamine agonists (DA), anticonvulsants, or opiates, used either alone or in any combination, but still, a subset of patients remains refractory to medical therapy and serious side effects such as augmentation and impulse control disorder may occur in patients with RLS under DA. Convincing treatment alternative are lacking but recently patients’ spontaneous reports of a remarkable and total remission of RLS symptoms following cannabis use has been reported. The antinociceptive effect of marijuana has been documented in many painful neurological conditions and the potential benefit of cannabis use in patients with refractory RLS should, therefore, be questioned by robust clinical trials. Here, we review basic knowledge of RLS and the putative mechanisms by which cannabis may exert its analgesic effects.
Keywords: Cannabis; Restless legs syndrome; Treatment.
Ghorayeb I. Ghorayeb I. Sleep Breath. 2020 Mar;24(1):277-279. doi: 10.1007/s11325-019-01978-1. Epub 2019 Dec 9. Sleep Breath. 2020. PMID: 31820197
Mackie SE, Winkelman JW. Mackie SE, et al. Drugs. 2017 Aug;77(12):1337-1344. doi: 10.1007/s40265-017-0773-6. Drugs. 2017. PMID: 28616844 Review.
de Oliveira CO, Carvalho LB, Carlos K, Conti C, de Oliveira MM, Prado LB, Prado GF. de Oliveira CO, et al. Cochrane Database Syst Rev. 2016 Jun 29;2016(6):CD006941. doi: 10.1002/14651858.CD006941.pub2. Cochrane Database Syst Rev. 2016. PMID: 27355187 Free PMC article. Review.
Konno M, Uchiyama M. Konno M, et al. Brain Nerve. 2009 May;61(5):549-57. Brain Nerve. 2009. PMID: 19514515 Review. Japanese.
Karroum E, Konofal E, Arnulf I. Karroum E, et al. Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):701-21. doi: 10.1016/j.neurol.2008.06.006. Epub 2008 Jul 24. Rev Neurol (Paris). 2008. PMID: 18656214 Review. French.
Worth H, O’Hara DV, Agarwal N, Collister D, Brennan F, Smyth B. Worth H, et al. Clin J Am Soc Nephrol. 2022 Jun;17(6):911-921. doi: 10.2215/CJN.11560821. Epub 2022 Jan 5. Clin J Am Soc Nephrol. 2022. PMID: 34987023 Review.